上海医药
上海醫藥
상해의약
SHANGHAI MEDICAL & PHARMACEUTICAL JOURNAL
2013年
3期
17-21
,共5页
大剂量地塞米松%多发性骨髓瘤%免疫性血小板减少症%淋巴瘤%急性淋巴细胞白血病
大劑量地塞米鬆%多髮性骨髓瘤%免疫性血小闆減少癥%淋巴瘤%急性淋巴細胞白血病
대제량지새미송%다발성골수류%면역성혈소판감소증%림파류%급성림파세포백혈병
high-dose dexamethasone%multiple myeloma%immune thrombocytopenia%lymphoma%acute lymphoblastic leukemia
地塞米松是一种长效糖皮质激素.大剂量地塞米松即40 mg/d 连用4 d 单独或联合其他药物治疗多发性骨髓瘤、免疫性血小板减少症、霍奇金淋巴瘤、非霍奇金淋巴瘤和急性淋巴细胞白血病的疗效确切,近年来已逐渐被纳入相关治疗指南或专家共识中.
地塞米鬆是一種長效糖皮質激素.大劑量地塞米鬆即40 mg/d 連用4 d 單獨或聯閤其他藥物治療多髮性骨髓瘤、免疫性血小闆減少癥、霍奇金淋巴瘤、非霍奇金淋巴瘤和急性淋巴細胞白血病的療效確切,近年來已逐漸被納入相關治療指南或專傢共識中.
지새미송시일충장효당피질격소.대제량지새미송즉40 mg/d 련용4 d 단독혹연합기타약물치료다발성골수류、면역성혈소판감소증、곽기금림파류、비곽기금림파류화급성림파세포백혈병적료효학절,근년래이축점피납입상관치료지남혹전가공식중.
Dexamethasone is a prolonged action glucocorticoid. Because of the exact effects, high-dose dexamethasone with 40 mg/d for 4 consecutive days used alone or combined in treating multiple myeloma, immune thrombocytopenia, Hodgkin’s lymphoma, non-Hodgkin’s lymphoma and acute lymphoblastic leukemia has been brought into related guidelines and consensus recently.
